25 May 2013
Keywords: GlaxoSmithKline, Human Genome Sciences, Benlysta, Lupus, USA, FDA
Article | 10 March 2011
After an agency delay following an advisory panel backing last November, the US Food and Drug Administration yesterday finally approved ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 March 2011
24 May 2013
© 2013 thepharmaletter.com